INSPIRE MEDICAL SYSTEMS INC (INSP)
US4577301090 - Common Stock
Taking everything into account, INSP scores 5 out of 10 in our fundamental rating. INSP was compared to 193 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for INSP as it has an excellent financial health rating, but there are worries on the profitability. INSP shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year INSP has reported negative net income.
INSP had a positive operating cash flow in the past year.
INSP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.12%, INSP is in the better half of the industry, outperforming 65.10% of the companies in the same industry.
With a decent Return On Equity value of -3.69%, INSP is doing good in the industry, outperforming 67.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.12% | ||
| ROE | -3.69% | ||
| ROIC | N/A |
ROA(3y)-8.44%
ROA(5y)-12.79%
ROE(3y)-10.36%
ROE(5y)-15.95%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a Gross Margin of 84.53%. This is amongst the best in the industry. INSP outperforms 95.31% of its industry peers.
In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for INSP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.08%
GM growth 5Y1.1%
2. Health
2.1 Basic Checks
INSP does not have a ROIC to compare to the WACC, probably because it is not profitable.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 44.46 indicates that INSP is not in any danger for bankruptcy at the moment.
INSP has a better Altman-Z score (44.46) than 98.44% of its industry peers.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 44.46 |
ROIC/WACCN/A
WACC9.97%
2.3 Liquidity
INSP has a Current Ratio of 7.60. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.60, INSP belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
INSP has a Quick Ratio of 7.17. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a Quick ratio of 7.17. This is amongst the best in the industry. INSP outperforms 85.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.6 | ||
| Quick Ratio | 7.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 54.88% over the past year.
The Revenue has grown by 53.18% in the past year. This is a very strong growth!
Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 65.32% on average per year.
EPS 1Y (TTM)54.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q390%
Revenue 1Y (TTM)53.18%
Revenue growth 3Y75.59%
Revenue growth 5Y65.32%
Revenue growth Q2Q39.6%
3.2 Future
INSP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.48% yearly.
Based on estimates for the next years, INSP will show a very strong growth in Revenue. The Revenue will grow by 20.75% on average per year.
EPS Next Y49.6%
EPS Next 2Y69%
EPS Next 3Y70.11%
EPS Next 5Y53.48%
Revenue Next Year26.27%
Revenue Next 2Y23.89%
Revenue Next 3Y22.58%
Revenue Next 5Y20.75%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INSP. In the last year negative earnings were reported.
Also next year INSP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, INSP is valued a bit cheaper than 68.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7389.17 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 70.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69%
EPS Next 3Y70.11%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INSPIRE MEDICAL SYSTEMS INC
NYSE:INSP (5/3/2024, 7:04:00 PM)
After market: 249.72 0 (0%)249.72
-1.47 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.57B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.12% | ||
| ROE | -3.69% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 84.53% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.92
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.6 | ||
| Quick Ratio | 7.17 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)54.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y49.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)53.18%
Revenue growth 3Y75.59%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y